Features of hyperplastic processes of the endometrium in the presence of arterial hypertension
DOI:
https://doi.org/10.12775/JEHS.2023.41.01.010Keywords
endometrial hyperplastic processes, endometrial hyperplasia, arterial hypertensionAbstract
Introduction: The relevance of studying endometrial hyperplastic processes (EHP) is due to their prevalence, impact on quality of life and high risk of malignancy. The structure of EHP takes from 20 to 40% in the pathology of reproductive system in women.
Objective: To evaluate the clinical and morphological features of hyperplastic processes of the endometrium in the presence of arterial hypertension.
Materials and Methods: 96 women with endometrial hyperplastic processes were examined during the study. The first group consisted of 57 women with endometrial hyperplasia with arterial hypertension. The second group included 39 patients with endometrial hyperplasia without arterial hypertension All patients involved in the study, were investigated by ultrasound on the machine "MyLab50" ( «Esaote», Italy) and videohysteroscopy ( «Karl Storz», Germany).
Results: In women of perimenopausal and postmenopausal age arterial hypertension was observed significantly more often compared to women of reproductive age (p<0.05). dysmenorrhea (40,4%; p <0.05), metrorrhagia (43,9%; p <0.05) and infertility (45,8 %; p <0.05) were significant more common for women with EHP and concomitant arterial hypertension. There are no significant differences in morphological forms between women with EHP with arterial hypertension and without hypertension. The presence of arterial hypertension had a significant effect on the risk of EHP recurrence (OR=6,0; CI=1,02-35,27; p<0,05).
Conclusions: Arterial hypertension was significantly more common in perimenopausal and postmenopausal women. Dismenorrhea, metrorrhagia and infertility were the most common clinical manifestations of EHP in patients with arterial hypertension. The presence of arterial hypertension is a reliable predictor of the occurrence of EHP recurrences during the one year.
References
Aune D., Sen A., Vatten L.J. Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies. Sci Rep. 2017; 7:44808.27
Epplein M., Reed S.D., Voigt L.F., Newton K.M., Holt V.L., Weiss N.S. Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am. J. epidemiol. 2008; 168(6): 563-70. doi: 10.1093/aje/kwn168.
Ganovska A., Kovachev S. Dependence between arterial hypertension and endometrial hyperplasia in pre- and postmenopausal women. International Journal of Gynecologic Cancer 2019; 29: A565. DOI: 10.1136/ijgc-2019-ESGO.1118
Korniyenko SM. Hiperplastychni protsesy endometriya u zhinok v pizn'omu reproduktyvnomu i premenopauzal'nomu periodi: shcho vplyvaye na retsydyvy. Bulletin of the Social Hygiene and Health Organization of Ukraine. 2017; 2: 39-47. Ukrainian.
Ricci E., Moroni S., Parazini F. et al. Risk factors for endometrial hyperplasia: results from case control study. Int. J. Gynecol. Cancer. 2002; 12(3): 257—60.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590.
Sen A., Vatten L.J. Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies. Sci Rep. 2017; 7:44808.27
Trimble CL. Management of endometrial precancers. Obstet. Gynecol. 2012; 120 (5): 1160-1175. DOI: http://10.1097/AOG.0b013e31826bb121.
Vovk IB., Gorban NE., Borisyuk OY. Giperplaziya endometriya (Clinical lecture). Woman's health. 2016; 5: 10-18. Ukrainian.
Unger T., Borghi C., Charchar F. et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75(6): 1334–1357. doi: 10.1161/HYPERTENSIONAHA.120.15026.
Zaporozhan V.N., Tatarchuk T.F., Dubinin V.G. Modern diagnostics and treatment of endometrial hyperplastic processes. Reproduktivnaya endokrinologiya 2012; 1: 5–12.
Zhang H, Kong W, Han C, Liu T, Li J, Song D. Correlation of Metabolic Factors with Endometrial Atypical Hyperplasia and Endometrial Cancer: Development and Assessment of a New Predictive Nomogram. Cancer Manag Res. 2021 Oct 18; 13:7937-7949. doi: 10.2147/CMAR.S335924.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Yaroslav Zemlianiy, Natalie Zemlyana
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 261
Number of citations: 0